Your Article Summary
See Latest ArticlesEffectiveness of Treatments for Metastatic Uveal Melanoma
American Journal of Ophthalmology, 06/26/09
Augsburger JJ et al. - Although median survival time after diagnosis of metastatic uveal melanoma tends to be substantially longer in selected patient subgroups subjected to aggressive invasive interventions than it is in unselected groups, much if not most of this apparent difference in survival is likely to be attributable to selection bias, surveillance bias, and publication bias rather than treatment-induced alteration of expected outcome.
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Choroidal granuloma as an initial manifestation of systemic sarcoidosis
International Ophthalmology, 12/15/09
Choroidal metastasis in a patient with small cell lung cancer discovered during treatment with chemotherapy
International Journal of Clinical Oncology, 12/15/09
Giant Choroidal Nevus: Clinical Features and Natural Course in 322 Cases
Ophthalmology, 12/15/09